AVTX vs PRLD: stock comparison and AI forecast
Avalo Therapeutics, Inc. (AVTX) and Prelude Therapeutics Inc (PRLD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AVTX Avalo Therapeutics, Inc.
- Price
- $7.25 -55.4% · 6M
- Market Cap
- $389M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
PRLD Prelude Therapeutics Inc
- Price
- $3.78 -19.1% · 6M
- Market Cap
- $389M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- AVTX and PRLD have similar market capitalizations ($389M and $389M).
- Over the last six months PRLD returned -19.1% and AVTX -55.4%.
- PRLD turns -269.8% of its revenue into net income, against -56685.3% for AVTX.
- PRLD carries 0.42 times debt per unit of equity, against 0.09 times for AVTX.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AVTX | PRLD |
|---|---|---|
| Market Cap | $389M | $389M |
| P/B Ratio | – | 2.91x |
| EPS | $-3.50 | $-1.02 |
| Book Value/Share | – | $1.30 |
| Revenue/Share | – | $0.22 |
| FCF/Share | – | $-0.32 |
Profitability & Margins
| Metric | AVTX | PRLD |
|---|---|---|
| ROE | -22.4% | -45.2% |
| ROA | -20.4% | -31.9% |
| ROIC | -19.4% | -44.5% |
| Operating Margin | -51614.7% | -300.6% |
| Net Margin | -56685.3% | -269.8% |
| EBT Margin | -56588.7% | -278.0% |
| Tax Rate | -0.2% | – |
Financial Health
| Metric | AVTX | PRLD |
|---|---|---|
| Current Ratio | 19.31x | 4.07x |
| D/E Ratio | 0.09x | 0.42x |
| Financial Leverage | 1.09x | 1.42x |
| Interest Coverage | -7.7x | – |
| Working Capital | $387M | $117M |
Cash Flow
| Metric | AVTX | PRLD |
|---|---|---|
| Operating Cash Flow | -$68M | -$33M |
| Free Cash Flow | – | -$33M |
| Capital Spending | – | $0.00M |
| FCF/Sales | – | -148.3% |
| CapEx/Sales | – | 0.0% |
Operational Efficiency
| Metric | AVTX | PRLD |
|---|---|---|
| Asset Turnover | – | 0.12x |
| Fixed Assets Turnover | – | 5.1x |
Income Statement
| Metric | AVTX | PRLD |
|---|---|---|
| Total Revenue | – | $22M |
| Operating Income | -$91M | -$67M |
| Net Income | -$100M | -$60M |
| R&D Expense | $59M | $69M |
Dividend & Shareholder Information
| Metric | AVTX | PRLD |
|---|---|---|
| Shares Outstanding | 54M | 103M |
| Net Income Growth | -292.0% | – |
| EPS Growth | -103.0% | – |
AVTX vs PRLD: stock comparison and AI forecast
Which is bigger, AVTX or PRLD?
AVTX and PRLD have similar market capitalizations ($389M and $389M).
Which stock performed better over the last six months, AVTX or PRLD?
Over the last six months PRLD returned -19.1% and AVTX -55.4%.
Which one does Intratio's AI model rank higher, AVTX or PRLD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.